WITH Qld and NSW now joining WA in supplying the RSV immunisation, Beyfortus (nirsevimab) to babies, experts want a national program to protect infants from RSV-related lung infections.
The Immunisation Foundation of Australia has backed calls for a national program such as the National Immunisation Program to include access to the vaccine.
The above article was sent to subscribers in Pharmacy Daily's issue from 26 Mar 24
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 26 Mar 24
